COMPANY PROFILE

ACCRETION PHARMACEUTICALS LIMITED

CIN: L21004GJ2023PLC146545
Status: Active
Incorporated: 29/11/2023
, ,

130,000,000

Authorized Capital

111,160,000

Paid Up Capital

3

Years Old

ACCRETION PHARMACEUTICALS LIMITED is a public company incorporated on 29/11/2023. The company is headquartered in , and operates in the Company limited by Shares sector.

Company Details
L21004GJ2023PLC146545
Active
29/11/2023
N/A years
130,000,000
111,160,000
Public
Company limited by Shares
No
RoC-Ahmedabad
25/09/2025
N/A
Registered Address
29 Xcelon Ind Park 1, B/h, Intas Pharmaceuticals, Vasna Chacharvadi, Ahmedabad, Sanand, Gujarat, India, 382213.
N/A
N/A
N/A
N/A
N/A
Complete Address:

29 Xcelon Ind Park 1, B/h, Intas Pharmaceuticals, Vasna Chacharvadi, Ahmedabad, Sanand, Gujarat, India, 382213.

Financial Details

Financial information and company details

Available Financial Information
130,000,000
111,160,000
31/03/2025
Active
29/11/2023
25/09/2025
Company Summary

ACCRETION PHARMACEUTICALS LIMITED is a public company incorporated on 29/11/2023. The company has an authorized capital of 130,000,000and a paid-up capital of 111,160,000.

The latest balance sheet is available as of 31/03/2025.

Company Directors

Board of directors and key management personnel

7Total Directors
7Active Directors
MAYUR POPATLAL SOJITRA
Director
Active
DIN
09****04
PAN
BW******9F
Appointment Date
29/11/2023
HARSHAD NANUBHAI RATHOD
Director
Active
DIN
09****92
PAN
AO******8B
Appointment Date
29/11/2023
VIVEK ASHOK KUMAR PATEL
Director
Active
DIN
09****57
PAN
AO******6D
Appointment Date
29/11/2023
HARDIK MUKUNDBHAI PRAJAPATI
Director
Active
DIN
09****03
PAN
AZ******5D
Appointment Date
29/11/2023
GRISHMA A SHEWALE
Director
Active
DIN
10****26
PAN
N/A
Appointment Date
13/07/2024
CHAND RAMESHBHAI KANABAR
Director
Active
DIN
10****50
PAN
N/A
Appointment Date
19/04/2025
NISHTHA HARIVANSHI PAMNANI
Director
Active
DIN
10****10
PAN
N/A
Appointment Date
10/06/2025

Pay per use

Need instant lookups?

Pay-per-use MCA, GST, and PAN tools — no subscription required.

Browse all tools